World Wires · story 113664 · official · 1 source(s)

SCHEDULE 13D/A: ARCH Venture Fund IX, L.P. discloses a stake in Vir Biotechnology, Inc.

Filed: 2026-11-06 AccNo: 0001012975-26-001020 Size: 22 KB

Open in the desk

Coverage

• SCHEDULE 13D/A: ARCH Venture Fund IX, L.P. discloses a stake in Vir Biotechnology, Inc. SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-11-06 23:55 UTC

What this site indexes